Linganisha mbinu

	TED-QoL / GO-QoL: Dodoso la Ubora wa Maisha kwa Ugonjwa wa Jicho la Tezi Dume	ThyPRO: Kiwango cha Matokeo Yanayoripotiwa na Mgonjwa Kuhusu Tezi Dume
Nyanja	Endokrinolojia	Endokrinolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2001	2009
Mwanzilishi	Caroline Terwee, Markus Gerding, Frank Dekker	Torquil Watt, Jens Bjørner, Marianne Groenvold
Aina	Patient self-report questionnaire	Patient self-report questionnaire
Chanzo asilia	Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779.	Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580.
Majina mbadala	GO-QoL, Graves Ophthalmopathy Quality of Life	ThyPRO-85, ThyPRO-39
Zinazohusiana	3	3
Muhtasari	The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment.	ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer.